nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Pazopanib—kidney cancer	0.00752	0.436	CbGbCtD
Zolmitriptan—CYP1A2—Erlotinib—kidney cancer	0.00537	0.311	CbGbCtD
Zolmitriptan—CYP1A2—Sorafenib—kidney cancer	0.00436	0.253	CbGbCtD
Zolmitriptan—Eletriptan—PTGS1—kidney cancer	0.0023	0.347	CrCbGaD
Zolmitriptan—Melatonin—CYP1A1—kidney cancer	0.00182	0.275	CrCbGaD
Zolmitriptan—Sumatriptan—ABCB1—kidney cancer	0.00138	0.209	CrCbGaD
Zolmitriptan—Eletriptan—ABCB1—kidney cancer	0.00112	0.169	CrCbGaD
Zolmitriptan—Nausea—Everolimus—kidney cancer	0.000411	0.000441	CcSEcCtD
Zolmitriptan—Diarrhoea—Sorafenib—kidney cancer	0.000411	0.000441	CcSEcCtD
Zolmitriptan—Hypertension—Paclitaxel—kidney cancer	0.00041	0.000441	CcSEcCtD
Zolmitriptan—Pruritus—Sunitinib—kidney cancer	0.000409	0.000439	CcSEcCtD
Zolmitriptan—Angiopathy—Capecitabine—kidney cancer	0.000407	0.000437	CcSEcCtD
Zolmitriptan—Immune system disorder—Capecitabine—kidney cancer	0.000405	0.000435	CcSEcCtD
Zolmitriptan—Myalgia—Paclitaxel—kidney cancer	0.000405	0.000435	CcSEcCtD
Zolmitriptan—Chest pain—Paclitaxel—kidney cancer	0.000405	0.000435	CcSEcCtD
Zolmitriptan—Arthralgia—Paclitaxel—kidney cancer	0.000405	0.000435	CcSEcCtD
Zolmitriptan—Anxiety—Paclitaxel—kidney cancer	0.000403	0.000433	CcSEcCtD
Zolmitriptan—Face oedema—Doxorubicin—kidney cancer	0.000403	0.000433	CcSEcCtD
Zolmitriptan—Decreased appetite—Gemcitabine—kidney cancer	0.000403	0.000432	CcSEcCtD
Zolmitriptan—Hypersensitivity—Dactinomycin—kidney cancer	0.000403	0.000432	CcSEcCtD
Zolmitriptan—Chills—Capecitabine—kidney cancer	0.000402	0.000432	CcSEcCtD
Zolmitriptan—Arrhythmia—Capecitabine—kidney cancer	0.0004	0.00043	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.0004	0.00043	CcSEcCtD
Zolmitriptan—Discomfort—Paclitaxel—kidney cancer	0.0004	0.000429	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Vincristine—kidney cancer	0.000399	0.000429	CcSEcCtD
Zolmitriptan—Dizziness—Sorafenib—kidney cancer	0.000397	0.000426	CcSEcCtD
Zolmitriptan—Pain—Gemcitabine—kidney cancer	0.000396	0.000425	CcSEcCtD
Zolmitriptan—Constipation—Gemcitabine—kidney cancer	0.000396	0.000425	CcSEcCtD
Zolmitriptan—Nausea—Erlotinib—kidney cancer	0.000396	0.000425	CcSEcCtD
Zolmitriptan—Dry mouth—Paclitaxel—kidney cancer	0.000396	0.000425	CcSEcCtD
Zolmitriptan—Mood swings—Doxorubicin—kidney cancer	0.000396	0.000425	CcSEcCtD
Zolmitriptan—Diarrhoea—Sunitinib—kidney cancer	0.000395	0.000424	CcSEcCtD
Zolmitriptan—Ataxia—Doxorubicin—kidney cancer	0.000393	0.000422	CcSEcCtD
Zolmitriptan—Asthenia—Dactinomycin—kidney cancer	0.000392	0.000421	CcSEcCtD
Zolmitriptan—Confusional state—Paclitaxel—kidney cancer	0.000391	0.00042	CcSEcCtD
Zolmitriptan—Erythema—Capecitabine—kidney cancer	0.00039	0.000419	CcSEcCtD
Zolmitriptan—Dehydration—Doxorubicin—kidney cancer	0.000388	0.000417	CcSEcCtD
Zolmitriptan—Oedema—Paclitaxel—kidney cancer	0.000388	0.000417	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Paclitaxel—kidney cancer	0.000388	0.000417	CcSEcCtD
Zolmitriptan—Abdominal pain—Vincristine—kidney cancer	0.000386	0.000415	CcSEcCtD
Zolmitriptan—Body temperature increased—Vincristine—kidney cancer	0.000386	0.000415	CcSEcCtD
Zolmitriptan—Infection—Paclitaxel—kidney cancer	0.000385	0.000414	CcSEcCtD
Zolmitriptan—Dysgeusia—Capecitabine—kidney cancer	0.000382	0.00041	CcSEcCtD
Zolmitriptan—Dizziness—Sunitinib—kidney cancer	0.000382	0.00041	CcSEcCtD
Zolmitriptan—Feeling abnormal—Gemcitabine—kidney cancer	0.000382	0.00041	CcSEcCtD
Zolmitriptan—Shock—Paclitaxel—kidney cancer	0.000382	0.00041	CcSEcCtD
Zolmitriptan—Vomiting—Sorafenib—kidney cancer	0.000382	0.00041	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000381	0.000409	CcSEcCtD
Zolmitriptan—Nervous system disorder—Paclitaxel—kidney cancer	0.00038	0.000408	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Paclitaxel—kidney cancer	0.00038	0.000408	CcSEcCtD
Zolmitriptan—Tachycardia—Paclitaxel—kidney cancer	0.000379	0.000407	CcSEcCtD
Zolmitriptan—Rash—Sorafenib—kidney cancer	0.000378	0.000406	CcSEcCtD
Zolmitriptan—Dermatitis—Sorafenib—kidney cancer	0.000378	0.000406	CcSEcCtD
Zolmitriptan—Back pain—Capecitabine—kidney cancer	0.000377	0.000405	CcSEcCtD
Zolmitriptan—Skin disorder—Paclitaxel—kidney cancer	0.000377	0.000405	CcSEcCtD
Zolmitriptan—Headache—Sorafenib—kidney cancer	0.000376	0.000404	CcSEcCtD
Zolmitriptan—Muscle spasms—Capecitabine—kidney cancer	0.000375	0.000403	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Paclitaxel—kidney cancer	0.000375	0.000403	CcSEcCtD
Zolmitriptan—Diarrhoea—Dactinomycin—kidney cancer	0.000374	0.000402	CcSEcCtD
Zolmitriptan—Anorexia—Paclitaxel—kidney cancer	0.00037	0.000397	CcSEcCtD
Zolmitriptan—Gastritis—Doxorubicin—kidney cancer	0.00037	0.000397	CcSEcCtD
Zolmitriptan—Muscular weakness—Doxorubicin—kidney cancer	0.000368	0.000395	CcSEcCtD
Zolmitriptan—Vomiting—Sunitinib—kidney cancer	0.000367	0.000394	CcSEcCtD
Zolmitriptan—Body temperature increased—Gemcitabine—kidney cancer	0.000366	0.000393	CcSEcCtD
Zolmitriptan—Tremor—Capecitabine—kidney cancer	0.000366	0.000392	CcSEcCtD
Zolmitriptan—Rash—Sunitinib—kidney cancer	0.000364	0.000391	CcSEcCtD
Zolmitriptan—Dermatitis—Sunitinib—kidney cancer	0.000364	0.000391	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Capecitabine—kidney cancer	0.000362	0.000389	CcSEcCtD
Zolmitriptan—Headache—Sunitinib—kidney cancer	0.000362	0.000388	CcSEcCtD
Zolmitriptan—Dysphagia—Doxorubicin—kidney cancer	0.000361	0.000387	CcSEcCtD
Zolmitriptan—Influenza—Doxorubicin—kidney cancer	0.000361	0.000387	CcSEcCtD
Zolmitriptan—Hypersensitivity—Vincristine—kidney cancer	0.00036	0.000386	CcSEcCtD
Zolmitriptan—Eosinophilia—Doxorubicin—kidney cancer	0.000357	0.000384	CcSEcCtD
Zolmitriptan—Nausea—Sorafenib—kidney cancer	0.000357	0.000383	CcSEcCtD
Zolmitriptan—Pancreatitis—Doxorubicin—kidney cancer	0.000354	0.00038	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000353	0.000379	CcSEcCtD
Zolmitriptan—Malaise—Capecitabine—kidney cancer	0.000352	0.000378	CcSEcCtD
Zolmitriptan—Angina pectoris—Doxorubicin—kidney cancer	0.000352	0.000377	CcSEcCtD
Zolmitriptan—Insomnia—Paclitaxel—kidney cancer	0.000351	0.000377	CcSEcCtD
Zolmitriptan—Vertigo—Capecitabine—kidney cancer	0.000351	0.000376	CcSEcCtD
Zolmitriptan—Asthenia—Vincristine—kidney cancer	0.00035	0.000376	CcSEcCtD
Zolmitriptan—Syncope—Capecitabine—kidney cancer	0.00035	0.000376	CcSEcCtD
Zolmitriptan—Leukopenia—Capecitabine—kidney cancer	0.000349	0.000375	CcSEcCtD
Zolmitriptan—Paraesthesia—Paclitaxel—kidney cancer	0.000348	0.000374	CcSEcCtD
Zolmitriptan—Vomiting—Dactinomycin—kidney cancer	0.000348	0.000373	CcSEcCtD
Zolmitriptan—Bronchitis—Doxorubicin—kidney cancer	0.000347	0.000373	CcSEcCtD
Zolmitriptan—Dyspnoea—Paclitaxel—kidney cancer	0.000346	0.000371	CcSEcCtD
Zolmitriptan—Somnolence—Paclitaxel—kidney cancer	0.000345	0.00037	CcSEcCtD
Zolmitriptan—Palpitations—Capecitabine—kidney cancer	0.000345	0.00037	CcSEcCtD
Zolmitriptan—Rash—Dactinomycin—kidney cancer	0.000345	0.00037	CcSEcCtD
Zolmitriptan—Nausea—Sunitinib—kidney cancer	0.000343	0.000368	CcSEcCtD
Zolmitriptan—Loss of consciousness—Capecitabine—kidney cancer	0.000343	0.000368	CcSEcCtD
Zolmitriptan—Dyspepsia—Paclitaxel—kidney cancer	0.000342	0.000367	CcSEcCtD
Zolmitriptan—Cough—Capecitabine—kidney cancer	0.00034	0.000365	CcSEcCtD
Zolmitriptan—Decreased appetite—Paclitaxel—kidney cancer	0.000337	0.000362	CcSEcCtD
Zolmitriptan—Hypertension—Capecitabine—kidney cancer	0.000337	0.000362	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000335	0.00036	CcSEcCtD
Zolmitriptan—Diarrhoea—Vincristine—kidney cancer	0.000334	0.000359	CcSEcCtD
Zolmitriptan—Pollakiuria—Doxorubicin—kidney cancer	0.000333	0.000358	CcSEcCtD
Zolmitriptan—Asthenia—Gemcitabine—kidney cancer	0.000332	0.000357	CcSEcCtD
Zolmitriptan—Chest pain—Capecitabine—kidney cancer	0.000332	0.000357	CcSEcCtD
Zolmitriptan—Arthralgia—Capecitabine—kidney cancer	0.000332	0.000357	CcSEcCtD
Zolmitriptan—Myalgia—Capecitabine—kidney cancer	0.000332	0.000357	CcSEcCtD
Zolmitriptan—Constipation—Paclitaxel—kidney cancer	0.000332	0.000356	CcSEcCtD
Zolmitriptan—Pain—Paclitaxel—kidney cancer	0.000332	0.000356	CcSEcCtD
Zolmitriptan—Anxiety—Capecitabine—kidney cancer	0.000331	0.000355	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000329	0.000354	CcSEcCtD
Zolmitriptan—Weight increased—Doxorubicin—kidney cancer	0.000328	0.000353	CcSEcCtD
Zolmitriptan—Discomfort—Capecitabine—kidney cancer	0.000328	0.000352	CcSEcCtD
Zolmitriptan—Pruritus—Gemcitabine—kidney cancer	0.000328	0.000352	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Doxorubicin—kidney cancer	0.000326	0.00035	CcSEcCtD
Zolmitriptan—Dry mouth—Capecitabine—kidney cancer	0.000325	0.000349	CcSEcCtD
Zolmitriptan—Nausea—Dactinomycin—kidney cancer	0.000325	0.000349	CcSEcCtD
Zolmitriptan—Pneumonia—Doxorubicin—kidney cancer	0.000324	0.000347	CcSEcCtD
Zolmitriptan—Dizziness—Vincristine—kidney cancer	0.000323	0.000347	CcSEcCtD
Zolmitriptan—Confusional state—Capecitabine—kidney cancer	0.000321	0.000345	CcSEcCtD
Zolmitriptan—Feeling abnormal—Paclitaxel—kidney cancer	0.00032	0.000343	CcSEcCtD
Zolmitriptan—Oedema—Capecitabine—kidney cancer	0.000318	0.000342	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000317	0.000341	CcSEcCtD
Zolmitriptan—Diarrhoea—Gemcitabine—kidney cancer	0.000317	0.00034	CcSEcCtD
Zolmitriptan—Infection—Capecitabine—kidney cancer	0.000316	0.00034	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000315	0.000339	CcSEcCtD
Zolmitriptan—Jaundice—Doxorubicin—kidney cancer	0.000314	0.000337	CcSEcCtD
Zolmitriptan—Stomatitis—Doxorubicin—kidney cancer	0.000314	0.000337	CcSEcCtD
Zolmitriptan—Shock—Capecitabine—kidney cancer	0.000313	0.000336	CcSEcCtD
Zolmitriptan—Urinary tract infection—Doxorubicin—kidney cancer	0.000313	0.000336	CcSEcCtD
Zolmitriptan—Conjunctivitis—Doxorubicin—kidney cancer	0.000313	0.000336	CcSEcCtD
Zolmitriptan—Nervous system disorder—Capecitabine—kidney cancer	0.000312	0.000335	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Capecitabine—kidney cancer	0.000312	0.000335	CcSEcCtD
Zolmitriptan—Tachycardia—Capecitabine—kidney cancer	0.000311	0.000334	CcSEcCtD
Zolmitriptan—Vomiting—Vincristine—kidney cancer	0.000311	0.000333	CcSEcCtD
Zolmitriptan—Skin disorder—Capecitabine—kidney cancer	0.000309	0.000332	CcSEcCtD
Zolmitriptan—Sweating—Doxorubicin—kidney cancer	0.000309	0.000331	CcSEcCtD
Zolmitriptan—Urticaria—Paclitaxel—kidney cancer	0.000308	0.000331	CcSEcCtD
Zolmitriptan—Rash—Vincristine—kidney cancer	0.000308	0.000331	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Capecitabine—kidney cancer	0.000308	0.00033	CcSEcCtD
Zolmitriptan—Dermatitis—Vincristine—kidney cancer	0.000308	0.00033	CcSEcCtD
Zolmitriptan—Haematuria—Doxorubicin—kidney cancer	0.000307	0.000329	CcSEcCtD
Zolmitriptan—Abdominal pain—Paclitaxel—kidney cancer	0.000307	0.000329	CcSEcCtD
Zolmitriptan—Body temperature increased—Paclitaxel—kidney cancer	0.000307	0.000329	CcSEcCtD
Zolmitriptan—Headache—Vincristine—kidney cancer	0.000306	0.000329	CcSEcCtD
Zolmitriptan—Epistaxis—Doxorubicin—kidney cancer	0.000304	0.000326	CcSEcCtD
Zolmitriptan—Anorexia—Capecitabine—kidney cancer	0.000304	0.000326	CcSEcCtD
Zolmitriptan—Sinusitis—Doxorubicin—kidney cancer	0.000302	0.000324	CcSEcCtD
Zolmitriptan—Vomiting—Gemcitabine—kidney cancer	0.000295	0.000316	CcSEcCtD
Zolmitriptan—Bradycardia—Doxorubicin—kidney cancer	0.000294	0.000316	CcSEcCtD
Zolmitriptan—Rash—Gemcitabine—kidney cancer	0.000292	0.000314	CcSEcCtD
Zolmitriptan—Dermatitis—Gemcitabine—kidney cancer	0.000292	0.000313	CcSEcCtD
Zolmitriptan—Headache—Gemcitabine—kidney cancer	0.00029	0.000312	CcSEcCtD
Zolmitriptan—Nausea—Vincristine—kidney cancer	0.00029	0.000312	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00029	0.000311	CcSEcCtD
Zolmitriptan—Rhinitis—Doxorubicin—kidney cancer	0.00029	0.000311	CcSEcCtD
Zolmitriptan—Insomnia—Capecitabine—kidney cancer	0.000288	0.000309	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Doxorubicin—kidney cancer	0.000287	0.000309	CcSEcCtD
Zolmitriptan—Pharyngitis—Doxorubicin—kidney cancer	0.000287	0.000308	CcSEcCtD
Zolmitriptan—Paraesthesia—Capecitabine—kidney cancer	0.000286	0.000307	CcSEcCtD
Zolmitriptan—Hypersensitivity—Paclitaxel—kidney cancer	0.000286	0.000307	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Doxorubicin—kidney cancer	0.000285	0.000306	CcSEcCtD
Zolmitriptan—Oedema peripheral—Doxorubicin—kidney cancer	0.000285	0.000306	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Doxorubicin—kidney cancer	0.000284	0.000305	CcSEcCtD
Zolmitriptan—Dyspnoea—Capecitabine—kidney cancer	0.000284	0.000305	CcSEcCtD
Zolmitriptan—Urethral disorder—Doxorubicin—kidney cancer	0.000283	0.000304	CcSEcCtD
Zolmitriptan—Dyspepsia—Capecitabine—kidney cancer	0.00028	0.000301	CcSEcCtD
Zolmitriptan—Asthenia—Paclitaxel—kidney cancer	0.000278	0.000299	CcSEcCtD
Zolmitriptan—Decreased appetite—Capecitabine—kidney cancer	0.000277	0.000297	CcSEcCtD
Zolmitriptan—Nausea—Gemcitabine—kidney cancer	0.000275	0.000296	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000275	0.000295	CcSEcCtD
Zolmitriptan—Pruritus—Paclitaxel—kidney cancer	0.000274	0.000295	CcSEcCtD
Zolmitriptan—Constipation—Capecitabine—kidney cancer	0.000272	0.000292	CcSEcCtD
Zolmitriptan—Pain—Capecitabine—kidney cancer	0.000272	0.000292	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—kidney cancer	0.000269	0.000289	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—kidney cancer	0.000268	0.000288	CcSEcCtD
Zolmitriptan—Diarrhoea—Paclitaxel—kidney cancer	0.000265	0.000285	CcSEcCtD
Zolmitriptan—Feeling abnormal—Capecitabine—kidney cancer	0.000262	0.000282	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—kidney cancer	0.000262	0.000281	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—kidney cancer	0.000261	0.00028	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Capecitabine—kidney cancer	0.00026	0.00028	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—kidney cancer	0.000259	0.000278	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—kidney cancer	0.000258	0.000277	CcSEcCtD
Zolmitriptan—Dizziness—Paclitaxel—kidney cancer	0.000257	0.000275	CcSEcCtD
Zolmitriptan—Urticaria—Capecitabine—kidney cancer	0.000253	0.000272	CcSEcCtD
Zolmitriptan—Abdominal pain—Capecitabine—kidney cancer	0.000252	0.00027	CcSEcCtD
Zolmitriptan—Body temperature increased—Capecitabine—kidney cancer	0.000252	0.00027	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—kidney cancer	0.000251	0.00027	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—kidney cancer	0.000247	0.000265	CcSEcCtD
Zolmitriptan—Vomiting—Paclitaxel—kidney cancer	0.000247	0.000265	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—kidney cancer	0.000246	0.000264	CcSEcCtD
Zolmitriptan—Rash—Paclitaxel—kidney cancer	0.000245	0.000263	CcSEcCtD
Zolmitriptan—Dermatitis—Paclitaxel—kidney cancer	0.000244	0.000262	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—kidney cancer	0.000244	0.000262	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—kidney cancer	0.000243	0.000261	CcSEcCtD
Zolmitriptan—Headache—Paclitaxel—kidney cancer	0.000243	0.000261	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—kidney cancer	0.000242	0.00026	CcSEcCtD
Zolmitriptan—Hypersensitivity—Capecitabine—kidney cancer	0.000235	0.000252	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—kidney cancer	0.000233	0.00025	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—kidney cancer	0.000231	0.000248	CcSEcCtD
Zolmitriptan—Nausea—Paclitaxel—kidney cancer	0.00023	0.000247	CcSEcCtD
Zolmitriptan—Asthenia—Capecitabine—kidney cancer	0.000228	0.000245	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—kidney cancer	0.000227	0.000243	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—kidney cancer	0.000226	0.000243	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—kidney cancer	0.000226	0.000242	CcSEcCtD
Zolmitriptan—Pruritus—Capecitabine—kidney cancer	0.000225	0.000242	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—kidney cancer	0.000225	0.000242	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—kidney cancer	0.000222	0.000239	CcSEcCtD
Zolmitriptan—Loss of consciousness—Doxorubicin—kidney cancer	0.000221	0.000237	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—kidney cancer	0.000219	0.000236	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—kidney cancer	0.000218	0.000234	CcSEcCtD
Zolmitriptan—Diarrhoea—Capecitabine—kidney cancer	0.000218	0.000234	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—kidney cancer	0.000217	0.000233	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—kidney cancer	0.000214	0.00023	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—kidney cancer	0.000214	0.00023	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—kidney cancer	0.000214	0.00023	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—kidney cancer	0.000213	0.000229	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—kidney cancer	0.000212	0.000227	CcSEcCtD
Zolmitriptan—Dizziness—Capecitabine—kidney cancer	0.000211	0.000226	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—kidney cancer	0.000209	0.000225	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—kidney cancer	0.000207	0.000222	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—kidney cancer	0.000205	0.00022	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—kidney cancer	0.000205	0.00022	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—kidney cancer	0.000204	0.000219	CcSEcCtD
Zolmitriptan—Vomiting—Capecitabine—kidney cancer	0.000202	0.000217	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—kidney cancer	0.000202	0.000217	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—kidney cancer	0.000201	0.000216	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—kidney cancer	0.000201	0.000216	CcSEcCtD
Zolmitriptan—Rash—Capecitabine—kidney cancer	0.000201	0.000216	CcSEcCtD
Zolmitriptan—Dermatitis—Capecitabine—kidney cancer	0.000201	0.000215	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—kidney cancer	0.0002	0.000215	CcSEcCtD
Zolmitriptan—Headache—Capecitabine—kidney cancer	0.000199	0.000214	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—kidney cancer	0.000199	0.000214	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—kidney cancer	0.000198	0.000213	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—kidney cancer	0.000196	0.00021	CcSEcCtD
Zolmitriptan—Nausea—Capecitabine—kidney cancer	0.000189	0.000203	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000187	0.000201	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—kidney cancer	0.000186	0.000199	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—kidney cancer	0.000184	0.000198	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—kidney cancer	0.000183	0.000196	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—kidney cancer	0.000182	0.000196	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—kidney cancer	0.000181	0.000194	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—kidney cancer	0.000178	0.000192	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000177	0.00019	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—kidney cancer	0.000176	0.000188	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—kidney cancer	0.000176	0.000188	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—kidney cancer	0.000169	0.000182	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000168	0.00018	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—kidney cancer	0.000163	0.000175	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—kidney cancer	0.000162	0.000174	CcSEcCtD
Zolmitriptan—Abdominal pain—Doxorubicin—kidney cancer	0.000162	0.000174	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—kidney cancer	0.000151	0.000162	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—kidney cancer	0.000147	0.000158	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—kidney cancer	0.000145	0.000156	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—kidney cancer	0.00014	0.000151	CcSEcCtD
Zolmitriptan—Dizziness—Doxorubicin—kidney cancer	0.000136	0.000146	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—kidney cancer	0.00013	0.00014	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—kidney cancer	0.000129	0.000139	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—kidney cancer	0.000129	0.000139	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—kidney cancer	0.000129	0.000138	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—kidney cancer	0.000122	0.000131	CcSEcCtD
Zolmitriptan—HTR1B—Signaling Pathways—AKAP13—kidney cancer	4.66e-05	0.00104	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CRABP1—kidney cancer	4.57e-05	0.00102	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ACY1—kidney cancer	4.44e-05	0.000994	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SFRP2—kidney cancer	4.41e-05	0.000987	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—POMC—kidney cancer	4.4e-05	0.000986	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GRB7—kidney cancer	4.36e-05	0.000975	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ANXA1—kidney cancer	4.29e-05	0.00096	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GRB7—kidney cancer	4.27e-05	0.000955	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ITPR2—kidney cancer	4.25e-05	0.000952	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—POMC—kidney cancer	4.09e-05	0.000916	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ITPR2—kidney cancer	4.05e-05	0.000907	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ITPR2—kidney cancer	3.97e-05	0.000888	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—MAPK1—kidney cancer	3.92e-05	0.000877	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF2—kidney cancer	3.9e-05	0.000872	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN2B—kidney cancer	3.88e-05	0.000868	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTT1—kidney cancer	3.88e-05	0.000868	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ACHE—kidney cancer	3.88e-05	0.000868	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.79e-05	0.000848	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PDHB—kidney cancer	3.77e-05	0.000845	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1R—kidney cancer	3.77e-05	0.000843	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—POMC—kidney cancer	3.76e-05	0.000843	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNA1—kidney cancer	3.67e-05	0.000822	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SCARB1—kidney cancer	3.67e-05	0.000821	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EIF4EBP1—kidney cancer	3.65e-05	0.000817	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HSPB1—kidney cancer	3.65e-05	0.000817	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS1—kidney cancer	3.63e-05	0.000813	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—RAF1—kidney cancer	3.63e-05	0.000813	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNA1—kidney cancer	3.6e-05	0.000805	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL2—kidney cancer	3.58e-05	0.000802	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EIF4EBP1—kidney cancer	3.57e-05	0.0008	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HSPB1—kidney cancer	3.57e-05	0.0008	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PSMD7—kidney cancer	3.56e-05	0.000797	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP2—kidney cancer	3.55e-05	0.000795	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKAP13—kidney cancer	3.55e-05	0.000795	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CCBL1—kidney cancer	3.55e-05	0.000795	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PSMD7—kidney cancer	3.39e-05	0.00076	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ANXA1—kidney cancer	3.39e-05	0.00076	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TSC1—kidney cancer	3.39e-05	0.00076	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—BCHE—kidney cancer	3.38e-05	0.000756	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SLC5A5—kidney cancer	3.34e-05	0.000747	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PSMD7—kidney cancer	3.32e-05	0.000744	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TSC1—kidney cancer	3.32e-05	0.000744	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ANXA1—kidney cancer	3.32e-05	0.000744	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FLT1—kidney cancer	3.29e-05	0.000736	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL2—kidney cancer	3.25e-05	0.000729	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GRB7—kidney cancer	3.25e-05	0.000728	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SLC2A1—kidney cancer	3.22e-05	0.000721	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FLT1—kidney cancer	3.22e-05	0.000721	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.21e-05	0.000719	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HIF1A—kidney cancer	3.1e-05	0.000694	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—POMC—kidney cancer	3.1e-05	0.000694	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TSC2—kidney cancer	3.09e-05	0.000693	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPAT—kidney cancer	3.08e-05	0.000689	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.08e-05	0.000689	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PAK1—kidney cancer	3.05e-05	0.000682	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUNB—kidney cancer	3.05e-05	0.000682	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.04e-05	0.00068	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—POMC—kidney cancer	3.03e-05	0.00068	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ITPR2—kidney cancer	3.02e-05	0.000676	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.01e-05	0.000673	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PAK1—kidney cancer	2.98e-05	0.000668	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUNB—kidney cancer	2.98e-05	0.000668	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KDR—kidney cancer	2.97e-05	0.000664	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APRT—kidney cancer	2.86e-05	0.000641	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—FH—kidney cancer	2.86e-05	0.000641	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—POMC—kidney cancer	2.81e-05	0.00063	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.8e-05	0.000626	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—POMC—kidney cancer	2.76e-05	0.000617	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNA1—kidney cancer	2.74e-05	0.000613	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KIT—kidney cancer	2.73e-05	0.000612	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—APC—kidney cancer	2.73e-05	0.000612	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EIF4EBP1—kidney cancer	2.72e-05	0.00061	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HSPB1—kidney cancer	2.72e-05	0.00061	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPC3—kidney cancer	2.69e-05	0.000602	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTP1—kidney cancer	2.69e-05	0.000601	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA2—kidney cancer	2.62e-05	0.000586	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—MAPK3—kidney cancer	2.62e-05	0.000586	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—POMC—kidney cancer	2.6e-05	0.000582	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BRAF—kidney cancer	2.57e-05	0.000575	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALAD—kidney cancer	2.55e-05	0.000571	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCB1—kidney cancer	2.54e-05	0.000569	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSMD7—kidney cancer	2.53e-05	0.000567	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSC1—kidney cancer	2.53e-05	0.000567	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ANXA1—kidney cancer	2.53e-05	0.000567	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF2—kidney cancer	2.49e-05	0.000558	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—MAPK1—kidney cancer	2.49e-05	0.000557	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.49e-05	0.000557	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN2B—kidney cancer	2.48e-05	0.000555	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTM1—kidney cancer	2.47e-05	0.000553	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FLT1—kidney cancer	2.45e-05	0.000549	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF2—kidney cancer	2.44e-05	0.000546	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.43e-05	0.000545	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN2B—kidney cancer	2.43e-05	0.000544	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1R—kidney cancer	2.41e-05	0.000539	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—PIK3CA—kidney cancer	2.38e-05	0.000533	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1R—kidney cancer	2.36e-05	0.000528	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—KRAS—kidney cancer	2.35e-05	0.000526	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1A1—kidney cancer	2.34e-05	0.000524	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.33e-05	0.000522	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PGK1—kidney cancer	2.33e-05	0.000522	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RAF1—kidney cancer	2.32e-05	0.00052	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—POMC—kidney cancer	2.31e-05	0.000518	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL2—kidney cancer	2.29e-05	0.000513	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LDHB—kidney cancer	2.29e-05	0.000512	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUNB—kidney cancer	2.27e-05	0.000509	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PAK1—kidney cancer	2.27e-05	0.000509	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RAF1—kidney cancer	2.27e-05	0.000509	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL2—kidney cancer	2.24e-05	0.000502	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PIK3CA—kidney cancer	2.16e-05	0.000484	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAF1—kidney cancer	2.14e-05	0.00048	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RELA—kidney cancer	2.13e-05	0.000478	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ERBB2—kidney cancer	2.12e-05	0.000475	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—POMC—kidney cancer	2.1e-05	0.00047	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MTOR—kidney cancer	2.09e-05	0.000469	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2—kidney cancer	2.08e-05	0.000466	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2—kidney cancer	2.04e-05	0.000456	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA9—kidney cancer	1.98e-05	0.000444	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—kidney cancer	1.98e-05	0.000444	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TSC2—kidney cancer	1.98e-05	0.000443	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1B—kidney cancer	1.96e-05	0.00044	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—kidney cancer	1.94e-05	0.000435	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.94e-05	0.000434	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TSC2—kidney cancer	1.94e-05	0.000434	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—kidney cancer	1.92e-05	0.00043	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—kidney cancer	1.9e-05	0.000425	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—kidney cancer	1.87e-05	0.00042	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—JUN—kidney cancer	1.87e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF2—kidney cancer	1.86e-05	0.000416	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—kidney cancer	1.86e-05	0.000416	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CTNNB1—kidney cancer	1.86e-05	0.000415	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN2B—kidney cancer	1.85e-05	0.000414	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTEN—kidney cancer	1.81e-05	0.000405	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1R—kidney cancer	1.8e-05	0.000402	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APC—kidney cancer	1.75e-05	0.000391	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIT—kidney cancer	1.75e-05	0.000391	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—kidney cancer	1.74e-05	0.000391	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RAF1—kidney cancer	1.73e-05	0.000388	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APC—kidney cancer	1.71e-05	0.000383	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIT—kidney cancer	1.71e-05	0.000383	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—kidney cancer	1.71e-05	0.000383	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CRABP1—kidney cancer	1.69e-05	0.000378	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK3—kidney cancer	1.67e-05	0.000375	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—kidney cancer	1.66e-05	0.000372	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—kidney cancer	1.64e-05	0.000368	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK3—kidney cancer	1.64e-05	0.000367	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—kidney cancer	1.63e-05	0.000366	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—kidney cancer	1.63e-05	0.000365	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—kidney cancer	1.61e-05	0.00036	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK1—kidney cancer	1.59e-05	0.000356	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ITPR2—kidney cancer	1.57e-05	0.000351	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK1—kidney cancer	1.56e-05	0.000349	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—kidney cancer	1.55e-05	0.000348	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK3—kidney cancer	1.55e-05	0.000346	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—kidney cancer	1.52e-05	0.000341	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—kidney cancer	1.5e-05	0.000337	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—kidney cancer	1.5e-05	0.000337	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—kidney cancer	1.49e-05	0.000333	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—kidney cancer	1.48e-05	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSC2—kidney cancer	1.48e-05	0.00033	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—kidney cancer	1.47e-05	0.00033	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK1—kidney cancer	1.47e-05	0.000329	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.45e-05	0.000324	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—kidney cancer	1.43e-05	0.00032	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ACHE—kidney cancer	1.43e-05	0.00032	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—kidney cancer	1.41e-05	0.000317	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—kidney cancer	1.39e-05	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—kidney cancer	1.39e-05	0.000311	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—kidney cancer	1.38e-05	0.000309	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAF1—kidney cancer	1.37e-05	0.000307	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RELA—kidney cancer	1.36e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB2—kidney cancer	1.36e-05	0.000304	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SCARB1—kidney cancer	1.35e-05	0.000303	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—kidney cancer	1.35e-05	0.000303	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAF1—kidney cancer	1.34e-05	0.000301	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS1—kidney cancer	1.34e-05	0.0003	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MTOR—kidney cancer	1.34e-05	0.0003	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RELA—kidney cancer	1.34e-05	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB2—kidney cancer	1.33e-05	0.000297	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMD7—kidney cancer	1.31e-05	0.000294	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MTOR—kidney cancer	1.31e-05	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIT—kidney cancer	1.3e-05	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APC—kidney cancer	1.3e-05	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—kidney cancer	1.28e-05	0.000286	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1B—kidney cancer	1.26e-05	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK3—kidney cancer	1.25e-05	0.000279	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BCHE—kidney cancer	1.25e-05	0.000279	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—kidney cancer	1.24e-05	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—kidney cancer	1.23e-05	0.000276	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.23e-05	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1B—kidney cancer	1.23e-05	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—kidney cancer	1.23e-05	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—kidney cancer	1.22e-05	0.000274	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTEN—kidney cancer	1.21e-05	0.000272	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—kidney cancer	1.2e-05	0.000269	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—kidney cancer	1.2e-05	0.000268	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUN—kidney cancer	1.2e-05	0.000268	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.19e-05	0.000266	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK1—kidney cancer	1.19e-05	0.000266	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNB1—kidney cancer	1.19e-05	0.000266	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—kidney cancer	1.17e-05	0.000263	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUN—kidney cancer	1.17e-05	0.000262	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNB1—kidney cancer	1.16e-05	0.00026	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTEN—kidney cancer	1.16e-05	0.000259	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.15e-05	0.000258	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—kidney cancer	1.13e-05	0.000254	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTEN—kidney cancer	1.13e-05	0.000254	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—kidney cancer	1.12e-05	0.000251	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—kidney cancer	1.04e-05	0.000234	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	1.03e-05	0.000231	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—kidney cancer	1.02e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAF1—kidney cancer	1.02e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RELA—kidney cancer	1.02e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB2—kidney cancer	1.01e-05	0.000227	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.01e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MTOR—kidney cancer	9.98e-06	0.000224	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—kidney cancer	9.91e-06	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK3—kidney cancer	9.88e-06	0.000221	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK3—kidney cancer	9.68e-06	0.000217	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—kidney cancer	9.61e-06	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—kidney cancer	9.41e-06	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK1—kidney cancer	9.4e-06	0.000211	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—kidney cancer	9.38e-06	0.00021	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	9.37e-06	0.00021	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK1—kidney cancer	9.21e-06	0.000206	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—kidney cancer	9.17e-06	0.000205	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—kidney cancer	9.1e-06	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—kidney cancer	8.94e-06	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUN—kidney cancer	8.92e-06	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—kidney cancer	8.88e-06	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	8.85e-06	0.000198	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—kidney cancer	8.7e-06	0.000195	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1A1—kidney cancer	8.63e-06	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTEN—kidney cancer	8.63e-06	0.000193	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—kidney cancer	8.56e-06	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	8.16e-06	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	7.99e-06	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—kidney cancer	7.89e-06	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—kidney cancer	7.79e-06	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—kidney cancer	7.73e-06	0.000173	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK3—kidney cancer	7.37e-06	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—kidney cancer	7.17e-06	0.000161	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.09e-06	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK1—kidney cancer	7.01e-06	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—kidney cancer	6.62e-06	0.000148	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—kidney cancer	6.44e-06	0.000144	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	6.09e-06	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—kidney cancer	5.89e-06	0.000132	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—kidney cancer	5.13e-06	0.000115	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTEN—kidney cancer	4.48e-06	0.0001	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.16e-06	7.07e-05	CbGpPWpGaD
